Pregnancy, fertility, and disease course in patients with Crohn's disease and ulcerative colitis

European Journal of Internal Medicine

Volumn 11, Issue 4, 2000, Pages 215-221

  Munkholm, Pia ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Disease course; Fertility; Inflammatory bowel disease; Pregnancy

Indexed keywords

AZATHIOPRINE; CIPROFLOXACIN; CYCLOSPORIN; MESALAZINE; METHOTREXATE; METRONIDAZOLE; STEROID; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

BREAST FEEDING; CIGARETTE SMOKING; CLEFT PALATE; CONTROLLED STUDY; CROHN DISEASE; DISEASE COURSE; DRUG INDUCED DISEASE; ENTERITIS; FEMALE; FEMALE FERTILITY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; NEPHROTOXICITY; PREGNANCY; REVIEW; TERATOGENICITY; ULCERATIVE COLITIS;

EID: 0033863319     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0953-6205(00)00088-1     Document Type: Review

References (24)

1. Sackett D., Richardson W.S., Rosenberg W., Haynes R.B. Evidence-based medicine. 1997;Churchill Livingstone.
2. Munkholm P. Crohn's disease - occurrence, course and prognosis. An epidemiological cohort study. Dan Med Bull. 44:(3):1997;287-302.
3. Langholz E. An epidemiological study based on a regional inception cohort with special reference to disease course and prognosis. Dan Med Bull. 46:(5):1999;400-415.
4. Baiocco P.J., Korelitz B.I. The influence of inflammatory bowel disease and its treatment on pregnancy and foetal outcome. J Clin Gastroenterol. 6:1984;211-216.
5. Mayberry J.F., Weterman I.T. European survey of fertility and pregnancy in women with Crohn's disease: a case control study by European collaborative group. Gut. 27:1986;821-825.
6. Willoughby C.P., Truelove S.C. Ulcerative colitis and pregnancy. Gut. 21:1980;469-474.
7. Orholm M., Munkholm P., Langholz E., Nielsen O.H., Sørensen T.I.A., Binder V. Familial occurrence of inflammatory bowel disease. N Engl J Med. 324:1991;84-88.
8. Bennet R.A., Rubin P.H., Present D.H. Frequency of IBD in offspring of couples both presenting with inflammatory bowel disease. Gastroenterology. 100:1991;1638-1643.
9. Castiglione F., Pignata S., Morace F., et al. Effect of pregnancy on the clinical course of a cohort of women with inflammatory bowel disease. Ital J Gastroenterol. 28:1996;199-204.
10. Nwokolo C.U., Tan W.C., Andrews H.A., Allan R.N. Surgical resections in parous patients with distal ileal and colonic Crohn's disease. Gut. 35:1994;220-223.
11. Johansen J., Stoltenberg M., Hansen M., et al. Serum YKL-40 concentrations in patients with rheumatoid arthritis: relation to disease activity. Rheumatology. 38:1999;618-626.
12. Kornfeld D., Cnattingius S., Ekbom A. Pregnancy outcomes in women with IBD - a population-based cohort study. Am J Obstet Gynecol. 177:1997;942-946.
13. Fonager K., Sorensen H.T., Olsen J., Dahlerup J.F., Rasmussen S.N. Pregnancy outcome for women with Crohn's disease: a follow-up study based on linkage between national registries. Am J Gastroenterol. 93:1998;2426-2430.
14. Baird D.D., Narendranathan M., Sandler R.S. Increased risk of preterm birth for women with inflammatory bowel disease. Gastroenterology. 99:1990;987-994.
15. Diav-Citrin O., Park Y.-H., Veerasuntharam G., et al. The safety of mesalamine in human pregnancy: a prospective controlled cohort study. Gastroenterology. 114:1998;23-28.
16. Marteau P., Tennenbaum R., Elefant E., Lemann M., Cosnes J. Foetal outcome in women with IBD treated during pregnancy with oral mesalazine. Alim Pharmacol Ther. 12:1998;1101-1108.
17. Marteau P., Devaux C.B. Mesalazine during pregnancy. Lancet. 344:1994;1708-1709.
18. Bell C.M., Habal F.M. Safety of topical 5-aminosalicylic acid in pregnancy. Am J Gastroenterol. 92:1997;2201-2202.
19. Christensen L.A. 5-Aminosalicylic acid containing drugs. Delivery, fate, and possible clinical implications in man. Dan Med Bull. 47:(1):2000;20-41.
20. Colombel J.F., Brabant G., Gubler M.C., et al. Renal insufficiency in infant: side-effect of prenatal exposure to mesalazine? Lancet. 344:1994;620-621.
21. Alstead E.M., Ritchie J.K., Lennard-Jones J.E., Farthing M.J.G., Clark M.L. Safety of azathioprine in inflammatory bowel disease. Gastroenterology. 99:1990;443-446.
22. Francella A., Dayan A., Rubin P., Chapman M., Present D. 6-Mercaptopurine (6-MP) is safe therapy for childbearing patients with IBD: a case controlled study. Gastroenterology. 110:1996;A909.
23. Mogadam M., Dobbins W.O., Korelitz B.I., Ahmed S.W. Pregnancy in IBD: the effects of sulphasalazine and corticosteroids on foetal outcome. Gastroenterology. 80:1981;72-76.
24. Subhani J.M., Hamilton M.I. Review article: the management of inflammatory bowel disease during pregnancy. Alim Pharmacol Ther. 12:(11):1998;1093-1153.